These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 6105792

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
    Elizur A, Segal S, Yeret A, Ben-David M.
    Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY.
    Neurosci Lett; 1979 Dec; 382(1-2):27-32. PubMed ID: 15911116
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Hypophyseal dysfunction and chronic hemodialysis].
    Holzer H, Goebel R, Pogglitsch H, Katschnig H, Leb G.
    Acta Med Austriaca; 1978 Dec; 5(3):96-7. PubMed ID: 752223
    [Abstract] [Full Text] [Related]

  • 32. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
    Schlienger JL, Kapfer MT, Singer L, Stephan F.
    Acta Psychiatr Belg; 1980 Dec; 80(5):584-99. PubMed ID: 6786002
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neuroendocrinological and biochemical effects of chronic neuroleptic treatment.
    Hippius H, Ackenheil M, Müller-Spahn F.
    Adv Biochem Psychopharmacol; 1985 Dec; 40():9-13. PubMed ID: 2862769
    [No Abstract] [Full Text] [Related]

  • 35. [Serum prolactin levels in chronic schizophrenics].
    Ravalli S, Barone R, Molinaro G, Leone NB.
    Minerva Psichiatr; 1987 Dec; 28(1):31-4. PubMed ID: 2888003
    [No Abstract] [Full Text] [Related]

  • 36. Anterior pituitary hormone secretion in chronic schizophrenia--an approach to neurohumoral mechanisms.
    Johnstone EC, Crow TJ, Mashiter K.
    Psychol Med; 1977 May; 7(2):223-8. PubMed ID: 877185
    [Abstract] [Full Text] [Related]

  • 37. Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
    Braddock LE, Blake IM.
    Br J Psychiatry; 1981 Nov; 139():404-7. PubMed ID: 6120732
    [Abstract] [Full Text] [Related]

  • 38. No association between bone mass and prolactin levels among patients with schizophrenia.
    Sugawara N, Yasui-Furukori N, Fujii A, Saito M, Sato Y, Nakagami T, Tsuchimine S, Kaneko S.
    Hum Psychopharmacol; 2011 Dec; 26(8):596-601. PubMed ID: 22105774
    [Abstract] [Full Text] [Related]

  • 39. The effect of chronic neuroleptic treatment on gonadotrophin release.
    Carter DA, McGarrick GM, Norton KR, Paykel ES, Prysor-Jones RA, Whitehead SA.
    Psychoneuroendocrinology; 1982 Dec; 7(2-3):201-7. PubMed ID: 6129671
    [Abstract] [Full Text] [Related]

  • 40. The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.
    Gründer G, Wetzel H, Hillert A, Jochum E, Hiemke C, Benkert O.
    Psychopharmacology (Berl); 1995 Feb; 117(4):472-8. PubMed ID: 7604150
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.